Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Using ML to Diagnose Chronic Kidney Disease in a Bias-Free, Privacy-Protecting, Physician-Friendly Manner

    Aug 9, 2023, 01:00 AM by User Not Found
    Bio-IT World | Carenostics is a healthcare AI startup founded with the mission of addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and ML on existing healthcare data.
    Full story
  • Generate Biomedicines’ R&D Data Platform to Support ML-Driven Drug Discovery

    Aug 8, 2023, 01:00 AM by User Not Found
    Bio-IT World | “Generate Biomedicines’ goal of leveraging machine-learning powered generative biology to discover and develop new drugs faster and cheaper is supported by an integrated and cohesive R&D data platform… FAIR to its core, this integrated data platform leverages industry best practices and lessons-learned from a talented team of informatics engineers to form the critical foundation of a unique company with equal parts ‘bio’ and ‘tech’.”
    Full story
  • Genedata Selector 9.0 Automates Critical Quality Attribute Assessment of Cell and Gene Therapy Products

    Aug 3, 2023, 10:02 AM by
    Full story
  • Lactabico Joins Biolabs Heidelberg, Establishes EU Presence

    Aug 3, 2023, 09:29 AM by
    The Lactocore Group has joined BioLabs Heidelberg, marking a significant expansion in the European Union of innovative research and development in the field of peptide therapy for the treatment of depression, anxiety and metabolic disorders.
    Full story
  • Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing

    Aug 3, 2023, 09:29 AM by
    Full story
  • An AI Tool for Lung Cancer Diagnosis in Indian Populations, Settings

    Aug 3, 2023, 01:00 AM by User Not Found
    Bio-IT World | The prognosis of lung carcinoma has changed since the discovery of molecular targets and their specific drugs. Somatic EGFR mutations have been reported in lung carcinoma, and these mutant proteins act as substrates for targeted therapies.
    Full story
  • SYGNATURE DISCOVERY ACCELERATES GLOBAL GROWTH WITH MAJOR NORTH AMERICAN ACQUISITION

    Aug 2, 2023, 09:05 AM by
    Leading integrated drug discovery partner, Sygnature Discovery (“Sygnature”) has announced its acquisition of one of North America’s largest discovery Contract Research Organisations, Canada-based NuChem Sciences. This acquisition cements Sygnature as one of the world’s largest players in integrated drug discovery phase solutions and advances their vision to become the global market leader.
    Full story
  • Titian Software enters a 3-year agreement with leading life science company

    Aug 2, 2023, 09:05 AM by
    Titian Software LTD and Evotec have signed a 3-year agreement to expand their collaboration around Titian Software’s Mosaic Sample Management Platform.
    Full story
  • Expert Speaker Lineup Revealed for Award Winning RBQM Event

    Aug 2, 2023, 09:05 AM by
    Expert Speaker Lineup Revealed for Award Winning RBQM Event Full agenda and keynote speakers announced for industry-leading risk-based quality management event focusing on the global transformation and evolution of RBQM, sponsored by CluePoints.
    Full story
  • EmendoBio Scientists Participate in National Neutropenia Network Patient Retreat

    Aug 2, 2023, 09:05 AM by
    Scientists attend national patient retreat and share scientific updates on investigational EMD-101 for severe congenital neutropenia treatment
    Full story
  • DNAnexus and BigOmics Analytics Join Forces to Improve Proteomics and Transcriptomics Data Visualization and Interpretation

    Aug 2, 2023, 09:05 AM by
    DNAnexus announced a collaboration with BigOmics Analytics to provide customers with a fully integrated solution to better understand large-scale proteomics and transcriptomics data.
    Full story
  • The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change

    Aug 2, 2023, 09:05 AM by
    The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change Clinical trial participants, caregivers and health professionals share unfiltered accounts of their personal health journeys and provide insights into their experience in clinical trials.
    Full story
  • Discovery To Creation: Highlights from the 2023 Single-Cell and AI in Medicine Symposium

    Aug 2, 2023, 01:00 AM by User Not Found
    Bio-IT World | The field of drug discovery is shifting its approach from viewing complex biology as something to be overcome using reductionist principles to something to embrace in a more holistic approach to cell biology.
    Full story
  • Not every protein-protein interaction impacts cancer drug design

    Aug 1, 2023, 09:12 AM by
    Researchers uncover a detailed action mechanism for protein MRG15, an important consideration for drugs targeting ASH1L which is overexpressed in many cancers. The findings from King Abdullah University of Science and Technology (KAUST), Saudi Arabia and the University of Michigan, U.S, could implicate the design of future cancer treatments.
    Full story
  • Platform Reduces Barriers Biologists Face In Accessing Machine Learning

    Aug 1, 2023, 01:00 AM by User Not Found
    Bio-IT World | A group of scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University and MIT are convinced that automated machine learning (autoML) is going to revolutionize biology by removing many of the technical barriers to using computational models to answer fundamental questions about sequences of nucleic acids, peptides, and glycans.
    Full story
  • African Pharmaceutical Market is expected to see a Double-Digit Growth by 2027 – Emerging Growth Opportunities in Africa

    Jul 28, 2023, 08:17 AM by
    Rapidly growing African population and urbanization, an increasing number of chronic diseases, and growing healthcare spending's are some of the primary factors driving the growth of the African pharmaceutical market.
    Full story
  • Revvity Signals Software and Scitara Expand Strategic Relationship to Accelerate Laboratory Digital Transformation

    Jul 28, 2023, 08:16 AM by
    Full story
  • Thermo Fisher Scientific Introduces New Liquid Chromatography Detector

    Jul 28, 2023, 08:16 AM by
    Full story
  • Huateng Pharma Announced To Attend CPhI Korea in August 2023

    Jul 27, 2023, 08:47 AM by
    Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production, with an annual capacity of more than 1 billion RMB. Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818
    Full story
  • Samsung Biologics Reports Second Quarter 2023 Financial Results

    Jul 27, 2023, 08:45 AM by
    Full story
  • «
  • 81 (current)
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy